NCT06608654

Brief Summary

Fetal distress is a common emergency in obstetrics, which refers to the combined symptoms of fetal health and life in utero due to acute or chronic hypoxia, with an incidence of 2.7% to 38.5%. Fetal distress is mainly related to abnormal amniotic fluid, umbilical cord entanglement and compression, which is an important reason for the increase of cesarean section rate during delivery. At present, the diagnosis of fetal distress mainly relies on electronic monitoring of fetal heart, and the false positive rate is high. Intrauterine pressure catheter has not been widely used because of the little effect of intrauterine treatment and the increase of infection. Endoscopy has been widely used in the diagnosis and treatment of various specialties at present, but the diagnosis and treatment during childbirth are still in a blind area. The characteristics of endoscopic visualization provide a new idea for the diagnosis and treatment of fetal distress during delivery, especially for the etiological diagnosis and treatment of umbilical cord factors. The use of intraauterine endoscope during delivery can make up for the defects of intrauterine pressure catheter, realize the visual diagnosis of the causes of fetal distress such as oligoamniotic fluid, meconium contamination of amniotic fluid, umbilical cord compression caused by entangling and true junction, etc. At the same time, it can also improve the intrauterine environment by perfusion of saline for the causes of fetal embarrassment, correct fetal distress, and extend the observation time during labor. It is beneficial to reduce caesarean section during labor.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for not_applicable

Timeline
4mo left

Started Oct 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress84%
Oct 2024Aug 2026

First Submitted

Initial submission to the registry

August 12, 2024

Completed
1 month until next milestone

First Posted

Study publicly available on registry

September 23, 2024

Completed
8 days until next milestone

Study Start

First participant enrolled

October 1, 2024

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 25, 2025

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

August 25, 2026

Expected
Last Updated

September 23, 2024

Status Verified

September 1, 2024

Enrollment Period

11 months

First QC Date

August 12, 2024

Last Update Submit

September 19, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • fetal distress rate

    fetal distress rate during first stage of labor

    through study completion, an average of 1 year

Secondary Outcomes (4)

  • vaginal delivery rate

    through study completion, an average of 1 year

  • Incidence of maternal infection

    through study completion, an average of 1 year

  • Neonatal asphyxia rate

    through study completion, an average of 1 year

  • neonatal NICU admission rate

    through study completion, an average of 1 year

Study Arms (1)

fetal distress

EXPERIMENTAL
Device: endoscope application

Interventions

Intrauterine bronchoscopy application for fetal distress during labor

fetal distress

Eligibility Criteria

Age20 Years - 45 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Subjects aged 20-45 years with single pregnancy;
  • Intrauterine fetal distress occurs during labor (during the first stage of labor), and the fetal membrane was already broken;
  • Fetal heart monitoring category II, after stopping oxytocin, oxygen inhalation, change of position, intravenous fluid and other measures can not improve;
  • Understand the research procedures, be able to follow the procedures of the research protocol, and voluntarily sign a written consent.

You may not qualify if:

  • Type III fetal heart monitoring for pregnant women who require emergency c-section
  • Pregnant women with GBS positive
  • Pregnant women suspected of chorioamniotic infection
  • Pregnant women have signs of reproductive system infection (vaginal inflammation, cervicitis, uterine infection)
  • Pregnant women suspected of uterine rupture
  • Pregnant women with abnormal contractions: excessive strong contractions
  • Check the fetus for serious deformities during pregnancy
  • Check pregnant women with serious abnormal functions of cardiovascular system, urinary system, digestive system, reproductive system and other organs

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

First Affiliated Hospital of Nanjing Medical University

Nanjing, Jiangsu, China

Location

MeSH Terms

Conditions

Fetal DistressFetal Hypoxia

Condition Hierarchy (Ancestors)

Signs and SymptomsPathological Conditions, Signs and SymptomsFetal DiseasesPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesHypoxiaSigns and Symptoms, Respiratory

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 12, 2024

First Posted

September 23, 2024

Study Start

October 1, 2024

Primary Completion

August 25, 2025

Study Completion (Estimated)

August 25, 2026

Last Updated

September 23, 2024

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will not share

Locations